Pharmaceutical companies run HCP engagement, sample distribution, speaker programs, medical affairs, and payer market access with heavy regulatory oversight. Strkr ships a CRM shaped for pharma work with sunshine-act compliance, HIPAA posture, and label-aware AI drafting on day one.
Pharmaceutical companies get sold Veeva CRM or IQVIA OCE as the industry default, with 6 to 12 month implementations and $180 to $400 per seat pricing. The alternative is a generic sales CRM retrofit that cannot carry the regulatory structure. The pain points below are what Strkr onboarding hears from pharma commercial, medical affairs, and compliance leaders.
An HCP engagement runs under FDA Office of Prescription Drug Promotion guidelines, state advertising rules, and physician payment transparency requirements. The engagement captures interaction type, discussion topics, label on-topic vs off-topic, samples distributed, and sunshine-act category. A generic CRM treats the engagement as a sales call. Strkr models the HCP engagement with the regulatory structure baked in.
Sample distribution runs under the Prescription Drug Marketing Act with signature required, lot tracking, inventory reconciliation, and expiration management. For controlled substances DEA Schedule II through V adds additional tracking requirements. Strkr's sample management surface runs the signature capture, lot assignment, inventory reconciliation, and expiration alert.
The Physician Payments Sunshine Act requires annual Open Payments reporting of every meal, consulting fee, speaker honorarium, travel reimbursement, and research payment. Missing a reportable interaction is a compliance failure. Strkr tags every HCP interaction with the sunshine-act category, captures the dollar value, and produces the Open Payments ready export.
A speaker program runs from speaker contract execution, through CME event delivery, through honorarium payment, through Open Payments reporting. Each stage has compliance checkpoints (fair market value, CME accreditation, attendee list capture). Strkr's speaker program workflow runs the end-to-end process with per-stage compliance checks.
Pharmaceutical companies maintain a firewall between medical affairs and commercial. Medical affairs responds to unsolicited medical information requests with scientific balance. Commercial promotes the approved label. The CRM must enforce the separation. Strkr's role model supports the medical-commercial firewall with HCP record visibility rules per role.
Market access conversations with payers (commercial insurers, Medicare Part D plans, Medicaid plans, PBMs) start 24 months before launch and run through formulary decisions, prior authorization criteria, and value-based contracts. Strkr's payer object captures the structure and drives the pre-launch engagement cadence.
The default CRM schema does not map to pharmaceutical work. Strkr ships a tunable pharma schema with HCP, HCO (healthcare organization), Sample Lot, Speaker Program, Payer, Advisory Board, Medical Information Request, and Call Report as first-class objects. The admin can rename or extend anything. The schema respects the medical-commercial firewall through role-based visibility.
An HCP in Strkr carries NPI, DEA number where applicable, state medical license numbers, specialty, hospital affiliation, prescribing posture (adopter, considerer, non-prescriber, former), publication record, speaker bureau status, advisory board participation, and sunshine-act exposure to date.
A healthcare organization in Strkr carries HCO type (hospital, clinic, group practice, GPO, ACO), affiliated HCPs, 340B status, GPO membership, and formulary adoption posture. The HCO object aggregates HCP engagement across the institution for account-level planning.
A sample lot in Strkr carries lot number, product, inventory quantity, expiration date, distribution to date, and remaining inventory. The lot object drives the sample distribution workflow with signature capture, lot assignment, and inventory reconciliation per DEA and PDMA requirements.
A speaker program ties to the speaker contract, the CME event (date, venue, topic), the attendee list, and the Open Payments reportable value. The object drives the speaker program workflow from contract to event to reporting with per-stage compliance checks.
A payer in Strkr carries payer type (commercial insurer, Medicare Part D, Medicaid plan, PBM, employer), lives covered, formulary tier (preferred, non-preferred, excluded), prior authorization criteria, value-based contract readiness, and account team contacts. The payer object drives the market access engagement cadence.
An advisory board in Strkr carries member list (with HCP references), meeting cadence, meeting topics, honorarium structure per meeting, and insight capture per meeting. The advisory board object drives the KOL engagement planning and the Open Payments reporting for member honoraria.
A medical information request ties to the HCP, the question category, the scientific response, label alignment status (on-label, off-label with appropriate framing), and response delivery date. The MIR object runs under the medical affairs scope, not commercial.
A call report captures the HCP engagement with date, duration, discussion topics, materials used (approved sales aids), samples distributed, and HCP commitments. The call report drives the next-visit planning and the sunshine-act reporting.
The Open Payments annual report is the highest-visibility compliance obligation for a pharmaceutical company. Missing a reportable interaction is a compliance failure that lands in the public database. Strkr's sunshine-act workflow runs from daily interaction capture through annual CMS submission.
Every HCP interaction captures the sunshine-act category at the moment of logging: meal, travel, consulting fee, honorarium, sample (which is separately tracked), research payment, charitable contribution, grant, education payment. The dollar value or in-kind value captures where applicable.
For interactions with a dollar value (consulting fee, speaker honorarium, advisory board fee, meals above threshold) Strkr runs a fair market value validation against the fair market value library. Interactions exceeding FMV route to compliance for pre-approval. The validation lands before the interaction commits.
Before the annual Open Payments publication HCPs can review and dispute their reportable interactions. Strkr's dispute resolution workflow routes the HCP dispute to compliance review with the original interaction detail. The resolution lands with the HCP acknowledgement before the final submission.
The annual Open Payments export produces the CMS-ready submission file with all reportable interactions, per the current year reporting template. The compliance officer reviews the export against the production system before submission. The submission lands with the audit trail preserved.
Several states (Vermont, Massachusetts, Minnesota, California, Nevada, Chicago) have additional transparency reporting requirements that go beyond the federal Open Payments program. Strkr tracks the state-level reportable categories and produces state-specific reports on the state-specific cadence.
The audit log captures every HCP interaction with the original data, any edits, the compliance review trail, and the final published value. In the event of an OIG review the audit log produces the complete record. Retention runs at the federal seven-year requirement.
Sample distribution runs under the Prescription Drug Marketing Act with signature capture, lot tracking, inventory reconciliation, and expiration management. Controlled substances add DEA scheduling requirements. Strkr's sample management surface runs the end-to-end sample flow.
Each rep carries an inventory per lot per product. Strkr tracks the inventory with incoming shipments (from the pharmaceutical warehouse), outgoing distributions (to HCPs), and physical reconciliation (periodic inventory audit). The inventory report surfaces for the rep and the compliance officer.
PDMA requires HCP signature at the moment of sample distribution. Strkr captures the signature on the rep's mobile device or tablet with the HCP acknowledgement, the product, the lot number, and the quantity. The signed record goes to the audit log immediately.
Every sample distribution assigns to a lot. If a lot is recalled Strkr produces the recall report with the full distribution list (HCPs who received samples from the lot, quantities, distribution dates). The recall notification goes to the affected HCPs through the standard communication workflow.
Samples with approaching expiration (90, 60, 30 days to expiration) surface in the expiration management view. The rep can prioritize distribution before expiration or return the samples to the warehouse. The report prevents the compliance embarrassment of distributing expired samples.
The quarterly reconciliation report compares the on-hand inventory (physical count) against the system inventory (incoming minus distributions). Discrepancies route to compliance review with the rep acknowledgement required. The reconciliation report lands in the compliance audit trail.
For controlled substance samples (DEA Schedule II through V) Strkr adds the DEA-required controls: witnessed destruction for expired samples, DEA 222 form handling where applicable, and the additional retention requirements. The schedule-specific workflow runs automatically based on product classification.
Most pharmaceutical companies run Veeva CRM or IQVIA OCE on top of Salesforce. The comparison below is Strkr's pharmaceutical posture versus that stack for a mid-size pharma commercial team.
| Feature | Strkr | Veeva CRM or IQVIA OCE on Salesforce |
|---|---|---|
| HCP as first-class object with NPI and DEA | Yes with prescribing posture. | Yes with heavy configuration. |
| Sample management with signature and lot | Built-in with DEA Schedule II handling. | Native in Veeva, add-on in some. |
| Sunshine Act Open Payments export | Built-in with FMV validation. | Add-on module typical. |
| Speaker program workflow | End to end with CME attendee capture. | Native in Veeva. |
| Medical-commercial firewall | Role-based visibility rules. | Native in Veeva. |
| HIPAA with BAA | Available on request without tier gate. | Enterprise plan typical. |
| AI drafting with label citation | Scope locked to medical info library. | Generic or none. |
| Setup time to first value | 42 to 90 business days. | 6 to 12 months typical. |
| Partner-led implementation retainer | None. | $20,000 to $40,000 per month typical. |
| Price per seat | Flat $29 to $119 per user per month. | $180 to $400 per user per month typical. |
The playbooks below are the patterns Strkr's onboarding team sees on pharmaceutical deployments, from a specialty biotech launch team to a mid-size pharma commercial organization.
A 48-person specialty biotech preparing for a rare-disease launch ran a bespoke Salesforce build with four AppExchange add-ons. The Vice President of Commercial wanted the launch-ready HCP CRM, sample management, and payer engagement in one tenant. Strkr onboarding ran a 60-business-day migration with the pharma schema on day one. The team was launch-ready in month 4.
A 120-rep oncology commercial team ran Veeva CRM with a $420,000 annual spend plus a Microsoft partner implementation retainer. The CFO ran the numbers. Strkr onboarding ran a 90-business-day migration (longer than default because of the Veeva export complexity). The HCP relationship book, sample tracking, and sunshine-act workflow ported over clean. Annual tool spend dropped 72 percent.
A 24-person medical affairs team at a mid-size pharma ran a bespoke Salesforce build with the commercial team. The Chief Medical Officer wanted the medical-commercial firewall enforced with distinct scope. Strkr onboarding configured the role model with the medical affairs scope (medical information requests, publication tracking, KOL engagement) separate from the commercial scope. The firewall landed clean.
A 180-rep established brand team at a Top 20 pharma ran OCE with 11 integration partners and a 5-year contract. Strkr onboarding ran a 180-business-day phased migration district by district across the full field force. Monthly tool spend dropped 68 percent. The field reps gained AI drafting for call summaries and next-visit planning.
A 32-person payer market access team at a specialty pharma ran a bespoke payer database plus Salesforce. The Vice President of Market Access wanted the payer book, formulary tracking, and value-based contract pipeline in one view. Strkr onboarding configured the payer object with per-payer formulary tier, PA criteria, and VBC readiness. The team saw the full market access book in one view for the first time.
Book a 30 minute call. We will walk through the pharma schema, the sunshine-act workflow, the sample management surface, and the medical-commercial firewall with your actual therapeutic area and team structure.
Yes. Strkr's sample management surface runs PDMA signature capture at the moment of distribution with HCP acknowledgement, product, lot number, and quantity. Lot assignment per distribution supports the lot recall workflow if needed. Expiration management surfaces samples approaching expiration. For DEA Schedule II through V controlled substances the additional controls (witnessed destruction, DEA 222 form, extended retention) run automatically based on product classification.
Every HCP interaction tags with the sunshine-act category and dollar value at the moment of logging. Fair market value validation runs on interactions with dollar value. The dispute resolution workflow runs with HCPs before publication. The annual Open Payments export produces the CMS-ready submission file for the compliance officer to review. The audit log captures the full compliance trail with seven-year retention per federal requirement.
Yes. The role model supports distinct medical affairs and commercial scope with per-role record visibility rules. Medical information requests, publication tracking, KOL insights, and advisory board insights live under medical affairs scope. Call reports, sample distributions, and commercial campaign data live under commercial scope. HCPs appear in both scopes but with different field visibility and different workflow access. The firewall configuration is auditable.
Strkr prices flat per seat at $29 per user per month on Starter, $59 on Pro, and $119 on Scale with SSO through Clerk, verified domains, and MFA. There is a 14-day trial on every tier. The Strkr AI add-on runs $49 per month per seat with 5,000 AI calls included (overage at $0.012 per call). A 120-rep team on Scale with the AI add-on runs about $20,160 per month, which is a fraction of the typical $40,000 to $60,000 per month Veeva CRM or IQVIA OCE licensing cost before implementation.
Yes. Strkr integrates with Veeva Vault for document management, Oracle Siebel for existing CRM data migration, IQVIA ChannelDynamics for prescription data, Komodo Health or IQVIA Formulary for payer data, and other pharma-industry data sources through the standard webhook spec with HMAC signing and a published OpenAPI spec. The integration is on your side, which keeps the data model clean.
Yes. SSO through SAML and OIDC is live on Scale through Clerk. Verified domains let the pharma team control which email domains authenticate against the tenant. MFA is live across every tier with TOTP and text-based verification. Audit retention runs tunable per tenant with 90-day default and extensible to the pharma retention requirements including 21 CFR Part 11 electronic record integrity. HIPAA with BAA is available on request without a tier gate. SOC 2 Type II is in progress with target completion in 2026-Q4.
No sales call, no migration consultant, no four-month implementation. Enter your card, get 14 days of the full Pro tier, cancel any time before day 14 with zero charge. Spin up a workspace, import your CSV, and have something useful before lunch.
